Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 9, 2008, Pages 991-996

  Abbatecola, Angela M ^a   Barbieri, Michelangela ^a   Rizzo, Maria R ^a   Grella, Rodolfo ^a   Laieta, Maria T ^a   Quaranta, Emma ^a   Molinari, Anna M ^a   Cioffi, Michele ^a   Fioretto, Paola ^b   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aging; Arterial stiffness; Cognitive decline; Microalbuminuria; Pulse wave velocity

Indexed keywords

ALBUMIN;

AGED; ARTERIAL STIFFNESS; ARTICLE; COGNITIVE DEFECT; DEMENTIA; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PULSE WAVE; RISK FACTOR;

EID: 54249113392     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.9.991     Document Type: Article

References (41)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
2. Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1988;4:437-451.
3. Temelkova-Kurkitschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Post-challenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23:1830-1834.
4. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non diabetic subjects. Lancet. 1988;2:530-533.
5. Hillege HL, Janssen WM, Bak AA, et al., Prevend Study Group. Microalbuminuria is common, also in a non-diabetic, non-hypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular mortality. J Intern Med. 2001;249:519-526.
6. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T. Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res. 2004;27:471-477.
7. Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344:14-18.
8. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med. 2004;164:1327-1333.
9. Suzuki H, Fukushima M, Usami M, et al. IGT with fasting hyperglycemia is more strongly associated with microalbuminuria than IGT without fasting hyperglycemia. Diabetes Res Clin Pract. 2004;64:213-219.
10. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52:2867-2873.
11. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization; 1999.
12. Moser DJ, Hoth KF, Robinson RG, et al. Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke. 2004;35:e369-e372.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
14. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
15. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension. 1995;26:485-490.
16. Lezak M, Howieson D, Loring D. Neuropsychological Assessment, Fourth Edition. Oxford, UK: Oxford University Press; 2004.
17. Reiten R, Wolfson D. The Halstead-Reitan Neuropsychologic Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
18. Lamberty GJ, Putnam SH, Chatel DM. Derived Trail Making Test indices. Neuropsychol Behav Neurol. 1994;7:230-234.
19. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol. 1996;36:378-384.
20. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
21. Takiuchi S, Rakugi H, Fujii H, et al Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res. 2003;12:945-951.
22. Abbatecola AM, Rizzo MR, Barbieri M, et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology. 2006;67:235-240.
23. Du XL, Eldelstein D, Dimmerler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the act site. J Clin Invest. 2001;108:1341-1348.
24. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Rev. 2000;34:119-136.
25. Giround H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006;100:328-335.
26. Lee KJ. Nitric oxide and the cerebral vascular function. J Biomed Sci. 2000;7:16-26.
27. Noiri E, Hu Y, Bahou WF, Keese CR, Giaever I, Goligorsky MS. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem. 1997;272:1747-1752.
28. Iadecola C. Atherosclerosis and neurodegeneration. Unexpected conspirators in Alzheimer's dementia. Arterioscler Thromb Vasc Biol. 2003;23:1951-1953.
29. Claassen JA, Jansen RW. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis. J Gerontol A Biol Sci Med Sci. 2006;61:267-271.
30. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C. A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol. 2001;281:H2417-H2424.
31. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. B-amyloid mediated vasoactivity and vascular endothelial damage. Nature. 1996;380:168-171.
32. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39:257-265.
33. Hillege HL, Fidler V, Diercks GF, et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-1782.
34. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. Stroke. 1997;28:1710-1716.
35. Mule G, Cottone S, Vadala A, et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med. 2004;256:22-29.
36. Pugh K, Lipsitz L. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging. 2002;23:421-431.
37. Hanon O, Haulon S, Lenoir H, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005;10:2193-2197.
38. Hanon O, Haulon S, Lenoir H, et al. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging. 1986;7:489-502.
39. Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004;44:631-636.
40. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke. 1998;29:2334-2340.
41. Brantsman AH, Atthobari J, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. What predicts progression or regression of urinary albumin excretion in the nondiabetic population? J Am Soc Nephrol. 2007;18:637-645.